Cargando…
Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma
The role of the positive RNA Pol II regulator, P-TEFb (positive transcription elongation factor b), in maintenance of the anti-apoptotic protein Mcl-1 and bortezomib (btz) resistance was investigated in human multiple myeloma (MM) cells. Mcl-1 was up-regulated in all MM lines tested, including borte...
Autores principales: | Zhang, Yu, Zhou, Liang, Leng, Yun, Dai, Yun, Orlowski, Robert Z., Grant, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601747/ https://www.ncbi.nlm.nih.gov/pubmed/28938651 http://dx.doi.org/10.18632/oncotarget.19761 |
Ejemplares similares
-
Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation
por: Bottardi, Stefania, et al.
Publicado: (2011) -
JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes
por: Lee, Schuyler, et al.
Publicado: (2020) -
Polo-Like Kinase 1 Inhibits the Activity of Positive Transcription Elongation Factor of RNA Pol II b (P-TEFb)
por: Jiang, Liangzhen, et al.
Publicado: (2013) -
P-TEFb as A Promising Therapeutic Target
por: Fujinaga, Koh
Publicado: (2020) -
ZASC1 Stimulates HIV-1 Transcription Elongation by Recruiting P-TEFb and TAT to the LTR Promoter
por: Bruce, James W., et al.
Publicado: (2013)